Managing Young Women with Breast Cancer
Emirates Oncology Conference
25 – 27 November, 2022

Conrad Etihad Towers, Abu Dhabi

United Arab Emirates

  • About Us
    • Organizing Committee
    • Scientific Committee
    • Scientific Sub Committee
  • Welcome Message
  • Program
    • 2022 Program At Glance
    • Day 1 Program
    • Day 2 Program
    • Day 3 Program
    • Meet the Expert Session
    • Full Program
  • Speakers
  • 2022 Partners
  • Download CME
  • Media
    • EOC 2022 Gallery
      • Photo Gallery
      • Video Gallery
    • EOC 2021 Gallery
    • EOC 2016 Gallery
    • EOC 2015 Gallery
    • EOC 2014 Gallery
  • Contact Us
25 – 27 November, 2022

Conrad Etihad Towers, Abu Dhabi

United Arab Emirates

Quick Links  
Quick Links
  • 2022 Program At Glance
  • 2022 Speakers

Scientific Committee

Home Scientific Committee

Khalid

Dr. Khalid Saeed Balaraj Flag

Chair of Oncology Service| United Arab Emirates

Tawam Hospital

United Arab Emirates

Khalid
Dr. Khalid Saeed Balaraj
Flag
Chair of Oncology Service , Tawam Hospital | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Friday, 2022-11-25
Organizing Committee

  00:00 - 23:55

Friday, 2022-11-25
Session 1 Plenary

  08:30 - 11:00

Friday, 2022-11-25
Session 6: Abstract presentations

  15:40 - 16:50

Lectures by this speaker
Friday, 2022-11-25
Welcome Note

  08:30 - 08:40

Friday, 2022-11-25
Panel Discussion

  09:40 - 10:00

Friday, 2022-11-25
Closing Remarks

  16:40 - 16:50

Jawaher

Dr. Jawaher Ali Ansari Flag

Acting Chief, Oncology Clinic| United Arab Emirates

Tawam Hospital

United Arab Emirates

Jawaher
Dr. Jawaher Ali Ansari
Flag
Acting Chief, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Friday, 2022-11-25
Organizing Committee

  00:00 - 23:55

Friday, 2022-11-25
Session 1 Plenary

  08:30 - 11:00

Friday, 2022-11-25
Session 6: Abstract presentations

  15:40 - 16:50

Sunday, 2022-11-27
Session 2: Genitourinary malignancies- I

  08:30 - 11:00

Sunday, 2022-11-27
Educational Sessions: Multi-Disciplinary Case Based Discussions

  14:00 - 16:50

Lectures by this speaker
Friday, 2022-11-25
Panel Discussion

  09:40 - 10:00

Sunday, 2022-11-27
Welcome Note

  08:30 - 08:32

Sunday, 2022-11-27
Panel Discussion and Q&A’s + Voting

  09:50 - 10:00

Sunday, 2022-11-27
Intensifying Therapy Earlier in the Disease Course , Are We Doing Enough to Improve Outcomes? - Supported by Bayer

  10:00 - 10:20

Sunday, 2022-11-27
Apalutamide from Clinical Trials to Clinical Practice - Supported by Janssen

  10:20 - 10:40

Sunday, 2022-11-27
Padcev® - Evolving landscape in the management of La/mUC - Supported by Astellas

  12:30 - 12:50

Sunday, 2022-11-27
Panel Discussion

  12:50 - 13:10

Sunday, 2022-11-27
Bladder Cancer Case Based Discussion

  15:40 - 16:25

Sunday, 2022-11-27
Updates on the Management of mRCC and Role of Cabozantinib in the 1st line Treatment - Supported by IPSEN

  16:25 - 16:45

Friday, 2022-11-25
30 years of Innovation & commitment to enhancing patient experience- Neulastim Onpro - Supported by KyowaKirin

  15:40 - 15:50

Sunday, 2022-11-27
Panel Discussion and Q & A

  10:40 - 10:50

Abdulrahman

Dr. Abdulrahman Sulaiman Bin Sumaida Flag

Chief of Radiotherapy| United Arab Emirates

Tawam Hospital

United Arab Emirates

Abdulrahman
Dr. Abdulrahman Sulaiman Bin Sumaida
Flag
Chief of Radiotherapy , Tawam Hospital | United Arab Emirates

Chief of Radiotherapy - Tawam Hospital

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Saturday, 2022-11-26
Session 6: Radiation oncology session

  14:00 - 15:40

Lectures by this speaker
Saturday, 2022-11-26
Panel Discussion

  15:20 - 15:30

Ernest

Dr. Ernest Johan Luiten Flag

Chief of Breast Cancer Center| United Arab Emirates

Tawam Hospital

United Arab Emirates

Ernest
Dr. Ernest Johan Luiten
Flag
Chief of Breast Cancer Center , Tawam Hospital | United Arab Emirates

Chief of Breast Cancer Center- Tawam Hospital

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Saturday, 2022-11-26
Session 3: Advanced Breast Cancer Session

  11:00 - 14:00

Lectures by this speaker
Sunday, 2022-11-27
Case Presentation Breast Cancer

  14:45 - 15:30

Muhammad Zafar

Dr. Muhammad Zafar Javed Flag

Chief of Palliative Care Clinics| United Arab Emirates

Tawam Hospital

United Arab Emirates

Muhammad Zafar
Dr. Muhammad Zafar Javed
Flag
Chief of Palliative Care Clinics , Tawam Hospital | United Arab Emirates

Chief of Palliative Care Clinics – Tawam Hospital

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Saturday, 2022-11-26
Session 4: Palliative Care

  11:00 - 14:00

Lectures by this speaker
Saturday, 2022-11-26
Introduction

  11:00 - 11:05

Saturday, 2022-11-26
Panel Discussion and Q&A’s

  12:40 - 13:00

Muhammad

Dr. Muhammad Faisal Khanani Flag

Chief of Hematology/Oncology PEDS| United Arab Emirates

Tawam Hospital

United Arab Emirates

Muhammad
Dr. Muhammad Faisal Khanani
Flag
Chief of Hematology/Oncology PEDS , Tawam Hospital | United Arab Emirates

Chief of Hematology/Oncology PEDS – Tawam Hospital

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Lectures by this speaker
Sunday, 2022-11-27
Welcome Note

  08:30 - 08:32

Sunday, 2022-11-27
Panel Discussion and Q&A’s

  10:10 - 10:30

Arif

Dr. Arif Raza Alam Flag

Chief of Hematology| United Arab Emirates

Tawam Hospital

United Arab Emirates

Arif
Dr. Arif Raza Alam
Flag
Chief of Hematology , Tawam Hospital | United Arab Emirates

Chief of Hematology – Tawam Hospital

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Lectures by this speaker
Saturday, 2022-11-26
Welcome Note

  08:30 - 08:32

Saturday, 2022-11-26
Panel Discussion and Q&A’s

  10:30 - 10:40

Saturday, 2022-11-26
A new Era in Front-Line CLL Management - Supported by Janssen

  09:50 - 10:10

Mohammad

Mr. Mohammad Mah'D Saleh Flag

Oncology Center Manager| United Arab Emirates

Tawam Hospital

United Arab Emirates

Mohammad
Mr. Mohammad Mah'D Saleh
Flag
Oncology Center Manager , Tawam Hospital | United Arab Emirates

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.

Sessions by this speaker
Friday, 2022-11-25
Scientific Committee

  00:00 - 23:55

Friday, 2022-11-25
Organizing Committee

  00:00 - 23:55

Friday, 2022-11-25
Session 4: Oncology Nursing session

  14:00 - 15:40

Lectures by this speaker
Friday, 2022-11-25
Are we Resilient in Cancer Care?

  12:00 - 12:20

Friday, 2022-11-25
Panel Discussion- Q&A’s

  12:20 - 12:40

Friday, 2022-11-25
CVAD Challenges – Expert Panel Discussion

  14:40 - 15:20

Congress Secretariat :
INDEX Conferences & Exhibitions Org. Est.
INDEX Conferences & Exhibitions Org. Est.

COPYRIGHT © 2023. ALL RIGHTS RESERVED.